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Abstract
The objectives of the study were to investigate the anti-tumour activity of Pinellia ternata polysaccharide in vivo, and
to preliminarily explore the possible mechanism of its antitumour action. Mouse model of Ehrlich ascites tumour (solid
tumour) was used to detect the serum SOD, MDA and GSH-Px levels in mouse and to measure the tumour inhibition rate and
survival prolongation rate. The results showed that Pinellia ternata polysaccharide had some tumour inhibitory effect.
Tumour weight of Pinellia ternata polysaccharide high-dose group was highly significantly different (P<0.01) compared with
the model group. Tumour weight between Pinellia ternata polysaccharide medium-dose group and model group also had a
significant difference (P<0.05). Moreover, in the Pinellia ternata polysaccharide high-dose group, survival prolongation rate
of ascites tumour mice reached 62.23%, and mouse serum SOD, MDA and GSH-Px levels also rose in varying degrees. The
study concluded that Pinellia ternata polysaccharide extract had some in vivo anti-tumour effects, which were probably
associated with the enhancement of the body’s ability to scavenge excess free radicals by improving the body’s enzyme
activity.
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Introduction
Pinellia ternata is the dried tuber of Pinellia ternate (Thunb.) Breit., which is a plant in the genus Pinellia of the
family Araceae. It has a long history of medicinal use, and was originally recorded in the "Shen Nong's Herbal Classic". Wild
Pinellia ternata is grown in most parts of China, mainly in Sichuan, Henan, Hubei, Guizhou and Anhui. It is warm in nature,
acrid in taste, slightly toxic, and enters spleen, stomach and lung meridians. It has the effects of drying dampness and
resolving phlegm, lowering adverse qi and preventing vomiting, relieving stuffiness and dissipating nodulation. It is used in
the external treatment of abscess swelling and subcutaneous nodules (Xiao, 2000). There are up to 17 plants of the genus
Pinellia or family Araceae used as Pinellia in folk medicine (Cai et al., 2004), of which only P. ternata is the genuine herb.
Studies on genuine Pinellia have mainly focused on its processing (Xiu et al., 2004). Based on the needs of clinical
medication, Pinellia ternata can be further processed as Qing Ban Xia (alum processed pinellia), Jiang Ban Xia (ginger
processed pinellia), Fa Ban Xia (pro formula pinellia), etc. Scholars at home and abroad have studied its chemical
constituents and found that it contains alkaloids such as L-ephedrine, choline and cavidine (Chen et al., 2006; Yamamoto,
1991; Kano et al., 1987; Maruno., 1997), organic acids such as linoleic acid and succinic acid (Zhang et al., 2002; Wu et al.,
2003), amino acids such as aspartic acid (Li et al., 1990), as well as some irritating ingredients such as calcium oxalate
raphides (Wu et al., 1999). In recent years, relevant studies have demonstrated the anticancer effect of Pinellia ternata extract
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(Zheng, 2004). In this paper, polysaccharide, another active constituent of Pinellia ternata, was taken as the study object to
investigate its anti-tumour effect and to explore its mechanism of action.
Materials and Methods
Drugs
The experimental include Pinellia ternata (Baidu Medicine Co., Ltd.), which was identified by Professor Sunjun
(Kunming Medical University); RPMI l640 medium (Gibco BRL); MTT (Sigma); and CTX (Hengrui Medicine Co., Ltd.,
Jiangsu);
Reagents
The reagents include superoxide dismutase (SOD) kit, malondialdehyde (MDA) kit, and glutathione peroxidase
(GSH-Px) kit (Jiancheng Bioengineering Institute, Nanjing)
Main instruments
The main instruments used in the study were as follows: AE31 inverted phase contrast microscope (Motic); SW-CJ-IF
clean bench (Suzhou Purification Equipment Factory); fully automatic microplate reader (Mod550, BioRad);
low-temperature refrigerated centrifuge (Eppendorf, Germany); electronic balance (Sartorius AG, Beijing); and blood
counting chamber (Qiujing Biochemical Instrument Factory, Shanghai).
Experimental animals
Km mice, half male and half female, weighing 18~22 g were purchased from the Laboratory Animal Center of China
Medical University. All experimental procedures were approved by the Animal Research Ethics Committee of Xinxiang
Medical College University
Mouse Ehrlich ascites carcinoma (EAC) tumour cell lines
EAC tumour cell lines were purchased from KeyGEN Biotech Co., Ltd.
Preparation of Pinellia ternata polysaccharide
On the basis of references (Xu et al., 2005; Wang et al., 2004), appropriate improvements were made to extract
Pinellia ternata polysaccharide by ultrasonic extraction method. The tuber of Pinellia ternata was crushed, soaked in
ethanol and ultrasonically extracted three times, and then filtered to obtain Pinellia ternata residue. The Pinellia ternata
residue was added with double distilled water at a solid-liquid ratio of 1:15, and ultrasonically extracted three times. Then the
filtrates were combined, concentrated under reduced pressure to a viscous state, dissolved in a small amount of double
distilled water, and added with a three-fold volume of 95% ethanol and precipitated for 24 h. After filtration and
freeze-drying, Pinellia ternata polysaccharide was obtained.
Inhibitory effect on Ehrlich ascites tumour (solid tumour) in mice
50 mice weighing around 20 g were taken and their left forelimb axillas were subcutaneously injected with 0.1 ml of
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Ehrlich ascites tumour cells (1.0 × 106 cells/mouse). 24 h later, the mice were divided into model group, CTX group, Pinellia
ternata polysaccharide high-, medium- and low-dose groups, giving a total of 5 groups with 10 mice each. The mice in the
treatment groups were intragastrically administered with 0.2 ml of Pinellia ternata polysaccharide extract (3 mg/mouse)
daily for 15 consecutive days, and the mice in the model group were intragastrically administered with 0.9% NaCl (0.2
ml/mouse) daily for 15 consecutive days. On the 22nd day from the implantation of tumour cells, mice were sacrificed by
cervical dislocation. Tumours were removed, weighed, and the tumour growth inhibition rate was calculated according to the
following formula:
Tumour growth inhibition rate (%) = (average tumour weight of model group - average tumour weight of treatment group /
average tumour weight of model group) × 100%
Experiment on survival time of mice
Mice weighing around 20 g were set up into Pinellia ternata polysaccharide high-dose group and model group
(n=10). Mice in the treatment group were intraperitoneally injected with 0.1 ml of Ehrlich ascites tumour cells (1.0 × 106
cells/mouse). 24 h later, the mice in the treatment group were intragastrically administered with 0.2 ml of Pinellia ternata
polysaccharide extract (3 mg/mouse) daily, and the mice in the model group were intragastrically administered with 0.9%
NaCl (0.2 ml/mouse) daily. Survival time of the mice was observed, and body weight of mice was measured on the 7th and
14th days after administration. Survival time prolongation rate of mice in the treatment group was calculated according to the
following formula:
Survival time prolongation rate of mice (%) = (average survival time of mice in treatment group - average survival time of
mice in model group / average survival time of mice in model group) × 100%.
Effects of Pinellia ternata polysaccharide on serum SOD, MDA and GSH-Px in mice
Blood samples were collected from mice by eyeball extirpation. The blood samples were then placed in a centrifuge
tube, and centrifuged at 3000 rpm for 5 min to obtain the serum. The assays were performed according to the kit instructions.
Statistical methods
The experimental data were analysed using SPSS 13.0 software. Comparisons between two groups were
performed using t-test, and pairwise comparisons among groups were performed using one-way ANOVA.
Results
Inhibitory effect of Pinellia ternata polysaccharide on Ehrlich ascites tumour in mice
The results for the inhibitory effect of Pinellia ternata polysaccharide extract on Ehrlich ascites tumour in mice
are as shown in Table 1. There was a highly significant difference (P<0.01) in tumour weight between Pinellia
ternata polysaccharide high-dose group and model group. Tumour weight of Pinellia ternata polysaccharide
medium-dose group was also significantly different (P<0.05) compared with the model group. Moreover, tumour
inhibition rates of the two groups were both greater than 30%, suggesting that the Pinellia ternata polysaccharide
extract has a significant inhibitory effect on solid tumour in EAC tumour-bearing mice. Tumour weight of Pinellia
ternata polysaccharide low-dose group was also reduced compared with the model group, but there was no
significant difference.
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Table 1: Inhibitory effect of Pinellia ternata polysaccharide extract on Ehrlich ascites tumour in mice
Group Dose (mg/Kg) Number of
animals
Tumour weight
(g)
Tumour inhibition
rate (%)
Model group - 10 2.48±0.59 -
CTX group 0.02g 10 0.72±0.37** 70.96
Pinellia ternata
polysaccharide
high-dose group
800 10 1.21±0.54** 51.21
Pinellia ternata
polysaccharide
medium-dose group
600 10 1.47±0.67* 40.73
Pinellia ternata
polysaccharide
low-dose group
400 10 1.89±0.72 23.79
Comparison with the model group, * P<0.05; ** P<0.01
Results for the effect of Pinellia ternata polysaccharide on survival time of EAC mice
Results for the effect of Pinellia ternata polysaccharide extract on body weight and survival time of EAC mouse are
as shown in Table 2. The average survival time of EAC mice in the treatment group was prolonged compared with the model
group, and the difference was statistically significant (P<0.01). The average body weight of mice in the treatment group was
reduced compared with the control group, and the difference was statistically significant (on the 7th day after administration,
P<0.05; on the 14th day after administration P<0.01).
Table 2: Effect of Pinellia ternata polysaccharide extract on body weight and survival time of EAC mouse
Body weight (g) of mice at different time periods
Group 1 d 7 d 14 d Survival time
Survival
prolongation
rate (%)
Model group 20.45±0.67 30.41±0.92 43.88±1.15 14.27±1.85 -
Pinellia ternata
polysaccharide
high-dose group
20.34±0.76 26.23±1.21* 35.17±1.69** 23.15±3.81** 62.23
Comparison with the model group, * P<0.05; ** P<0.01
Effect of Pinellia ternata polysaccharide on serum SOD, MDA and GSH-Px in mice
The results for the effect of Pinellia ternata polysaccharide on serum SOD, MDA and GSH-Px in mice are as shown
in Table 3. Pinellia ternata polysaccharide can significantly improve serum SOD enzyme activity of mice (P<0.05), which
contributes to the scavenging of superoxide anions. Pinellia ternata polysaccharide can also reduce serum MDA level in
mice, indicating that it has the function of protecting cells from damage. Reduction of hydrogen peroxide by specific catalytic
reduced glutathione of glutathione peroxidase can play a role in protecting cell membrane structure and functional
completeness, GSH-Px level increased slightly in the Pinellia ternata polysaccharide group.
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Table 3: Results for the effect of Pinellia ternata polysaccharide on serum SOD, MDA and GSH-Px in mice
Group SOD activity（U/mg） MDA(nmol/mg) GSH-PX(U)
Model group 620.6±6.2 11.2±0.23 1234.5±10.1
Pinellia ternata
polysaccharide
high-dose group
715.7±7.1* 6.8±0.31* 1259.6±8.9
Comparison with the model group, * P<0.05
Discussion
Polysaccharides are widely present in animals, plants and microorganisms. A large number of modern
pharmacological and clinical studies have shown that the polysaccharide compounds are a type of immunomodulators which
have the functions of immune receptor activation and immune improvement. Among them, the activity of plant
polysaccharides are the most studied. In recent years, with their unique functions, the plant polysaccharides have been widely
used in the studies concerning improvement of the body's immune capacity, and enhancement of the body's antioxidant and
anti-tumour effects (Li et al., 1996; Li et al., 2004). Pinellia ternata polysaccharide is composed of a variety of sugars
such as fucose, glucose, galactose, rhamnose and ribose, which has a wide range of biological activity. This experiment
demonstrated that the Pinellia ternata polysaccharide not only has an inhibitory effect on tumour growth, but also can
prolong the survival time of EAC mice. The tumour inhibitory effect of Pinellia ternata polysaccharide is closely associated
with its antioxidant action, which can improve the body's enzyme activity and effectively remove excess free radicals.
References
1. Cai Shi-zhen, Zou Zhong-mei, Xu Li-zhen, Yang Shilin. (2004) Research progress on the medicinal plants of the genus
Pinellia. Foreign Medical Sciences, Section of Chinese Medicine, 26 (1): 17.
2. Chen Ping, Li Chuan, Liang Shupiao, Song Guoqiang, Sun Yan, Shi Yanhong, Xu Songlin, Zhang Jiwen, Sheng
Shuqun, Yang Yiming, Li Min. (2006) Characterization and quantification of eight water-soluble constituents in tubers
of Pinellia ternata and in tea granules from the Chinese multiherb remedy Xiaochaihu-tang. Journal of
Chromatography B, 843: 183-193.
3. Kano Yoshihiro, Arimoto Yoshiko, Cho Chang-dae, Tamura Kiyomi, Yasuda Masaho. (1987) Marker Substance for
"Pinelliae Tuber" Prescribed in "Shohangekabukuryo-To". The Japanese Journal of Pharmacognosy, 41 (4): 282.
4. Li Jie, Zhang Chu-qing. (2004) Immunoregulatory and antitumoral activities of Chinese herbal medicinal
polysaccharides. Chinese Journal of Veterinary Medicine, 40 (11):31-33.
5. Li Jin-feng, Guo Jing-wen, Huang Xin-fu. (1996) Study on the enhancing effect of polyporus polysaccharide, lentinan
and mycobacterial polysaccharide on lymphokine-activated killer cell activity. Chinese Journal of Integrated
Traditional and Western Medicine, 1996, 16 (4): 224-226.
6. Li Xian-duan, Hu Shi-lin, Yang Lian-ju. (1990) Analysis of amino acids and inorganic elements in Pinellia crude drugs.
China Journal of Chinese Materia Medica, 15 (10): 37-35.
7. Maruno Masao. (1997) Active principles of Pinelliae tuber and new preparation of crude drug. Journal of Traditional
Medicines, 14 (2): 81.
8. Wang Ya-fei, Bi Hong-mei. (2004) Study on ultrasonic extraction technology of lentinan. Inner Mongolia Science
Technology and Economy, 14: 124-125.
Li et al., Afr J Tradit Complement Altern Med. (2013) 10(5):380-385
http://dx.doi.org/10.4314/ajtcam.v10i5.27
385
9. Wu Hao, Li Wei. (1999) Study on irritating ingredients of Pinellia ternate. China Journal of Chinese Materia
Medica, 24 (12): 725-730.
10. Wu Hao, Zhang Ke-wei, Li Wei, Sun Ye, Shen Xiu-hong. (2003) Study on the chemical constituents of Pinellia ternata.
Chinese Traditional and Herbal Drugs, 34 (7): 593-594.
11. Xiao Pei-gen. (2000) Modern Chinese Materia Medica. Vol.1. Beijing: Chemical Industry Press, 372.
12. Xiu Yan-feng, Hong Xiao-kun, Wang Zhi-hua. (2004) Progress of studies on preparation of Rhizoma Pinelliae. Chinese
Traditional Patent Medicine, 26 (1): 38.
13. Xu Ling-chuan, Zhang Hua, Xu Chang-sheng, Wang Jian-ping. (2005) Exploration of optimum technology for
ultrasonic extraction of Ganoderma lucidum polysaccharides. China Journal of Chinese Materia Medica, 30
(6): 471-472.
14. Yamamoto F. (1991) Pharmaceutical formulations containing radical removers as antioxidants. CA, 114: 88687.
15. Zhang Ke-wei, Wu Hao, Wu Lu-ling. (2002) A Study on Component of Aliphatic Acid in Rhizoma Pinelliae
Ternatae Praeparata. Journal of Nanjing University of Traditional Chinese Medicine, 18 (5): 291-292.
16. Zheng Guo-can. (2004) Study on anti-tumor activity of Pinellia ternata extract. Journal of Sichuan Traditional Chinese
Medicine, 22 (9): 9-11.
